Carl Byrnes
Stock Analyst at Northland Capital Markets
(3.04)
# 1,416
Out of 5,090 analysts
26
Total ratings
52.63%
Success rate
11.87%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BWAY BrainsWay | Maintains: Outperform | $19 → $23 | $17.27 | +33.18% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $32.70 | +68.22% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $25.46 | +21.76% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $7.06 | +77.05% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.65 | +263.64% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.84 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $16.54 | +51.15% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $3.65 | +6,475.34% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $27.35 | +192.50% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $6.93 | +231.89% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $3.73 | +543.43% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.22 | +89,990.09% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.31 | - | 1 | Sep 27, 2017 |
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $17.27
Upside: +33.18%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $32.70
Upside: +68.22%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $25.46
Upside: +21.76%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $7.06
Upside: +77.05%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.65
Upside: +263.64%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.84
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $16.54
Upside: +51.15%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $3.65
Upside: +6,475.34%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $27.35
Upside: +192.50%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $6.93
Upside: +231.89%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $3.73
Upside: +543.43%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.22
Upside: +89,990.09%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.31
Upside: -